LON:ALK - Alkemy Capital Investments PLC
Executive Summary
Alkemy Capital Investments PLC (LON:ALK) is a London-listed investment company focused on early-stage technology and growth opportunities, with Tees Valley Lithium serving as a principal investment and project-development exposure. It operates within Financial Services and the Shell Companies industry, and its small market capitalisation and limited trading liquidity position it as a high-volatility small-cap holding.
The investment case requires successful development of its portfolio assets, with the five-year Glencore binding offtake agreement for up to 40% of Tees Valley Lithium production providing the principal hard catalyst as the project advances towards financing and commercial operation; the key near-term catalyst is binding project financing, for which no confirmed date is available. The primary risk is that development, funding or commercial milestones fail to materialise, while dilution, illiquidity and limited portfolio transparency compound the downside.
SPECULATIVE BUY. Conviction Score: 49/100. The view would improve if Tees Valley Lithium secured binding financing and demonstrated clear delivery towards commercial production, and it would weaken if the company announced a materially dilutive fundraise, failed to advance the project, or disclosed the loss of a material contract.
Thesis break: A materially dilutive equity raise, failure to secure binding project financing for Tees Valley Lithium, loss of the Glencore offtake agreement, or a disclosed material impairment of the project would invalidate the investment thesis regardless of the share price.
Business Model
Alkemy generates investment returns principally through capital appreciation and exits from its portfolio rather than through a recurring operating revenue stream. Its returns can therefore arise from share disposals, dividends, fair-value uplifts or partial and full exits, making reported earnings less predictable than those of a conventional operating company.
The principal disclosed commercial asset is Tees Valley Lithium, where Alkemy has exposure through its investment in the project. The binding offtake agreement with a Glencore unit covers up to 40% of planned production for five years, providing an identified route to market for part of the project's output. Alkemy's economic interest, project financing requirements, development timetable and expected revenue participation are not quantified sufficiently in the supplied primary evidence to calculate a reliable revenue mix, operating margin or earnings multiple.
Alkemy's competitive advantage is not a conventional operating moat. It depends on sourcing suitable investments, securing attractive commercial arrangements and demonstrating that its portfolio companies can progress from development to commercialisation. Its small size may provide access to opportunities unavailable to larger investors, but that advantage is offset by limited disclosure, concentration risk, potential equity dilution and the possibility that shareholders cannot trade positions efficiently.
Financial Snapshot
Recent Catalysts
[2026-05-29] - Alkemy published its audited Annual Report and Accounts for the year ended 31 January 2026. The report remains the principal available source for assessing the portfolio, financial position and risk disclosures. Source: Alkemy Capital Investments PLC, Annual Report and Financial Statements.
[2026-06-10] - Alkemy issued formal notice of its Annual General Meeting, which was scheduled for 3 July 2026 at 11.00 a.m. BST. The meeting has already taken place and is relevant to shareholder oversight, although the supplied evidence does not include voting outcomes. Source: Alkemy Capital Investments PLC, Notice of AGM.
[2026-05-04] - Alkemy upgraded its 2026 full-year financial outlook. The announcement concerned Alkemy and its listings in Copenhagen and Frankfurt, but the supplied excerpt does not provide the revised numerical guidance or enough information to establish its direct financial impact on LON:ALK. Source: GlobeNewswire, Alkemy Capital Investments PLC company announcement.
[2026-05-04] - The company announced that Tees Valley Lithium had signed a binding offtake agreement with a Glencore unit for up to 40% of production. This was a concrete commercial milestone for the project, although it does not by itself guarantee project completion because financing, construction and commissioning requirements remain. Source: Reuters via TradingView, Alkemy Capital Investments PLC announcement.
Thesis Evaluation
Bull Case (16% weight)
Tees Valley Lithium converts the Glencore offtake into operational value by securing binding project financing, progressing construction and preserving the agreement for up to 40% of production. Completion of funding and credible commissioning progress would support a re-rating from the depressed market price, with a 350p target over 12 months. Alkemy would also need to provide greater portfolio transparency without material dilution for this outcome to be sustained.
Base Case (48% weight)
The Glencore offtake and government grant support keep Tees Valley Lithium credible, but development remains financing-dependent and earnings stay difficult to forecast. Alkemy's absence of a meaningful earnings multiple, combined with continued small-cap illiquidity, supports a 225p 12-month target, broadly in line with the current 225.21p price. The shares are likely to remain volatile until project financing, construction timing and Alkemy's economic entitlement are clearer.
Bear Case (36% weight)
Tees Valley Lithium fails to secure acceptable financing, construction is delayed or the commercial package is weakened, leaving Alkemy dependent on further capital raising. A materially dilutive issue, further decline in underlying value or limited trading liquidity could take the shares to 180p over 12 months, below the 52-week low of 183.6p.
Key Risks
- Project financing and execution risk: Tees Valley Lithium may not secure acceptable financing or complete construction and commissioning on the required timetable, delaying value realisation. Estimated probability: 35%. Impact: severe.
- Dilution risk: Alkemy may need additional equity before portfolio assets generate sufficient proceeds, potentially diluting existing shareholders. Estimated probability: 40%. Impact: severe.
- Illiquidity risk: The company's small market capitalisation and limited trading volume may make it difficult for investors to enter or exit positions without material price impact. Estimated probability: 45%. Impact: moderate.
- Portfolio concentration risk: Concentrated exposure to a small number of development-stage assets means one adverse development could dominate overall portfolio performance. Estimated probability: 35%. Impact: severe.
- Limited disclosure risk: Insufficiently detailed disclosure of portfolio values, project economics and ownership prevents investors from making a robust independent valuation. Estimated probability: 40%. Impact: moderate.
- Commercial contract risk: The Glencore offtake covers only up to 40% of planned production and remains exposed to completion, delivery and financing conditions. Estimated probability: 25%. Impact: severe.
Who Should Own It / Avoid It
Ideal for: experienced small-cap investors who can tolerate severe volatility, limited liquidity and a multi-year holding period of at least three years, and who understand that Alkemy is an early-stage investment company rather than an earnings-generating operating business. Position sizing should be small enough to absorb a substantial decline, including a fall below the current 225.21p price toward the 180p bear-case target.
Avoid if: you require recurring earnings, a conventional valuation framework, dependable dividend income or the ability to trade a sizeable position quickly and at a predictable price. The shares are unsuitable for investors who cannot tolerate dilution risk, project-development uncertainty or the possibility that several portfolio milestones fail simultaneously.
Recommendation
SPECULATIVE BUY - 49/100. The tier reflects genuine hard-catalyst support from the five-year Glencore offtake for up to 40% of Tees Valley Lithium production, but that benefit is offset by negative EPS, an unknown P/E, potential dilution, illiquidity and limited portfolio transparency. An upgrade would require binding project financing, clearer commercial and financial disclosure, and a credible path to construction without material dilution. A downgrade would follow a materially dilutive raise, failure to secure financing, loss or material impairment of the offtake agreement, or other evidence that Tees Valley Lithium is not advancing as expected. At the current price of 239.30p the shares trade at or above our base-case target of 225.00p: the base case is fully priced, existing holders should consider trimming, and new positions are not advised above 195.00p.
The probability-weighted value across our three scenarios is 228.80p, 4% below the current price of 239.30p - the market is currently pricing the shares ahead of our probability-weighted view. Levels below are derived from the scenario targets and probabilities above, not from percentage offsets to today's price.
below 195.00p - below this level the upside to the base-case target (225.00p) is at least 2x the downside to the bear case (180.00p), the minimum risk/reward we require before committing new capital.
between 195.00p and 225.00p - the base case is not yet fully priced, so existing holders are paid to wait, but new money gets no margin of safety in this zone.
above 225.00p - at this level the base case is fully reflected in the price and anything beyond it is paying for a bull scenario we weight at 16%.
if A materially dilutive equity raise, failure to secure binding project financing for Tees Valley Lithium, loss of the Glencore offtake agreement, or a disclosed material impairment of the project would invalidate the investment thesis regardless of the share price, regardless of price - the bear target of 180.00p is the backstop, not an arbitrary percentage stop.
Conviction Trend
Latest conviction: 49/100. Trend versus prior report: Flat.
| Report date | Conviction |
|---|---|
| 2026-10-28 | 49 |
| 2026-08-09 | 49 |
Sources
Market data: DYOR HQ proprietary market data workflow.
Public sentiment and news flow: Company announcements, regulatory announcements, public financial news flow, investor-relations materials and third-party market commentary were reviewed to assess the offtake agreement, development progress, market performance and investor debate.
Primary source types: Regulatory announcements, audited annual reports and financial statements, company press releases, company investor-relations materials and news-wire reporting of issuer announcements.
Key sources
- Alkemy Capital Investments PLC Stock Price Today | LON: ALKALK Live - Investing.com
- Q4 2026 investment outlook
- Alkemy Capital Investments Plc (ALK.L) Stock Price, News, Quote & History - Yahoo Finance
- Alkemy Capital Investments PLC, ALK:LSE summary - FT.com
- Alkemy Capital Investments (ALK) Share Price, Stock Value, News & Analysis
- Alkemy Capital Investments PLC (ALKALK)
- Alkemy Capital Investments Plc (LSE:ALK) Jumps +3.93% on ...
- Alkemy Capital Investments Plc (ALK.L)
- Exclusivity Agreement Signed with Ara Partners - (ALK)
- Alkemy Capital Investments RNS Announcements | ALK RNS Announcements | Investegate
Analysis generated 2026-10-28. Market data as of 2026-11-13.